Giant cellulitis-like Sweet syndrome in the setting of autoimmune disease  by Kaminska, Edidiong Celestine Ntuen et al.
J AM ACAD DERMATOL
SEPTEMBER 2014
e94 LettersNocardiosis is caused by the gram-positive, fila-
mentous, partially acid-fast bacilli Nocardia, which
includes more than 50 ubiquitous, slow growing
aerobic species.1 Approximately 500 to 1000 cases of
nocardiosis occur in the United States per year.2
Primary cutaneous nocardiosis, most often caused by
Nocardia brasiliensis, typically affects immunocom-
petent individuals with a history of trauma and is
grouped into three entities: lymphocutaneous infec-
tion, mycetoma, and superficial skin infection
including ulceration, abscess, and cellulitis. N aster-
oides complex typically causes skin infection from
hematogenous dissemination from a pulmonary
focus and is frequently associated with systemic
disease.3 Treatment should include evaluation
for systemic disease as well as a minimum of 6
weeks of antibiotic therapy with trimethoprim-
sulfamethoxazole, the treatment of choice for no-
cardiosis; treatment may be needed for up to 1 year.
Given the difficulty in isolating Nocardia spp, it is
crucial to notify the laboratory if nocardiosis is
suspected so that the appropriate time (3 to 21
days) and growth conditions are provided.1,3,4 As
demonstrated in this case, it is imperative for the
clinician to follow up on abnormal or unexpected
results, and to contact the laboratory and other
involved physicians. Dermatologists must be aware
of this potentially difficult to diagnose organism as a
potential cause of nonhealing ulceration and other
cutaneous infections.
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setting of autoimmune disease
To the Editor: An unusual presentation of Sweet
syndrome, giant cellulitis-like type, has recently
been reported in the setting of malignancy and
morbid obesity.1 We report a case of giant
cellulitis-like Sweet syndrome in a patient with
autoimmune disease in the absence of malignancy.
A 54-year-old woman with history of sicca
syndrome, recurrent primary biliary cirrhosis (PBC)
despite a liver transplant for PBC 16 years previously,
and morbid obesity presented with a new red rash of
at least 3 days’ duration. Shewas initially hospitalized
for Escherichia coli bacteremia (1 month before rash
onset) that was treated with intravenous cefepime
for 2 weeks; subsequent bacterial blood cultures
were negative. Despite successful eradication of the
bacteremia, chills and fevers associated with the new
rash developed. Initially the rash was treated as
cellulitis but did not respond to treatment with
intravenous vancomycin.
On examination (Fig 1), there weremultiple large,
scattered, erythematous, edematous, indurated
papules and confluent plaques on her buttocks,
extremities, and trunk; the eruption progressed to
involve the head and neck. Punch biopsies of a
papule and plaque on the patient’s back
revealed prominent papillary dermal edema with a
mixed inflammatory cell infiltrate composed of
abundant neutrophils intermixed with lymphocytes,
histiocytes, and eosinophils (Fig 2), consistent with
Sweet syndrome. Leukocytoclastic vasculitis was
not noted. Serum blood counts and chemistry
demonstrated a normocytic anemia with hemo-
globin of 8.1 g/dL, normal white blood count of
4.1 K/L (with a slightly increased neutrophil count
of 77%), and increased creatinine of 1.7 mg/dL.
Tissue cultures for bacteria and fungi were negative.
The patient was treated with a prednisone taper over
a course of 40 days. The lesions improved rapidly
within 48 hours after initiation of treatment. Rare
clinical presentations of Sweet syndrome include
necrotizing fasciitis and cellulitic types,1-5 and do
not respond to antibiotics.3 Widespread ‘‘giant
cellulitis-like’’ Sweet syndrome, such as presented
in this case, was recently reported in 3 patients.1
All of the cases described obese patients
with recurrent fever and widespread infiltrated
Fig 1. Giant cellulitis-like Sweet syndrome. Initial
presentation with erythematous, edematous, indurated
papules and confluent plaques on the right back
(superior) and buttock (inferior; intergluteal cleft marked
by arrow).
Fig 2. Giant cellulitis-like Sweet syndrome pathology.
Prominent papillary dermal edema (top arrow) with
abundant dermal neutrophils (bottom arrow).
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Letters e95plaques with bullous characteristics. Histopathology
revealed classic findings of Sweet syndrome. Two
patients were found to have an underlying
malignancy (multiple myeloma or breast cancer);
the other patient had no identified malignancy or
autoimmune disease.
To our knowledge, an extensive cellulitic
presentation of Sweet syndrome has only been
described in the 3 patients mentioned here. Like in
these cases, our patient had severe widespread
eruption of giant cellulitis-like plaques and was
morbidly obese. However, to date, no malignancies
have been identified in our patient. Because
Sweet syndrome may herald onset or recurrence
of malignancy,1,3 routine screenings and close
follow-up are recommended. Our patient had classicSweet syndrome in the setting of precedent
bacteremia and inflammatory diseases (sicca
syndrome and PBC), yet she presented with unusual
giant cellulitis-like features. It is likely that giant
cellulitis-like Sweet syndromemay be an uncommon
clinical presentation for the different variants of
Sweet syndrome and may not be restricted to the
malignancy type.
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Cutaneous polyarteritis nodosa presenting as a
solitary blue toe
To the Editor: A woman in her 30s with a history of
Crohn disease, quiescent on mesalamine, presented
with a 1-year history of mild purple discoloration of
the left great toe, which progressed to painful,
burning nodules limiting movement of the digit.
Her symptoms did not fluctuate with changing
